VistaGen Therapeutics Company Presentation

www.vistagen.com 13 Screening N=183 Placebo Baseline Public Speaking and Social Interaction Challenge N=98 Placebo Public Speaking and Social Interaction N=46 PH94B Public Speaking and Social Interaction N=45 PH94B Phase 2 SAD Study: Public Speaking Liebowitz, MR, Salman, E, Nicolini, H, Rosenthal, N, Hanover, R, Monti. L (2014). Effect of an acute intranasal aerosol dose of PH94B on social and performance anxiety in women with social anxiety disorder. Am. J. Psychiatry 171:675-682 Visit 2 Visit 3 Visit 1 Follow-up Safety Visit 4